Table of Contents
Table of Contents
ABSTRACT
1. INTRODUCTION – NEW OPPORTUNITIES FOR ESTIMATION OF CARDIOVASCULAR SIDE EFFECTS IN ANTIDEPRESSANT THERAPY
2. SIDE EFFECTS OF ANTIDEPRESSANT DRUGS – SEVERE IMPAIRMENT IN OVERDOSE
3. DEPRESSION, ANTIDEPRESSANT THERAPY AND AUTONOMIC NERVOUS SYSTEM – ASSOCIATION WITH CARDIAC DISORDERS
4. AUTONOMIC NERVOUS SYSTEM, HEART RATE VARIABILITY (HRV) AND PROGNOSIS – PRINCIPLES OF HRV
5. DEPRESSION, ANTIDEPRESSANT THERAPY AND HEART RATE VARIABILITY – SYNOPSIS OF THE LITERATURE
6. INTOXICATION WITH ANTIDEPRESSANT DRUGS – MECHANISMS OF CARDIAC IMPAIRMENT
7. CHANGES OF HEART RATE VARIABILITY IN TCA INTOXICATION – DETAILED INFORMATION ON DOXEPIN
8. RISK OF HIGHER INCIDENCE OF ARRHYTHMIC EVENTS IN DOXEPIN OVERDOSE – DIFFERENTIATION OF HRV MINIMUM AND LF/HF INCREASE
9. ARRHYTHMIC EVENTS AND SYMPATHOVAGAL BALANCE – CORRELATION OF ARRHYTHMIC INCIDENCE AND LF/HF INCREASE
10. HRV ANALYSIS IN TIME COURSE AND PHASE DEPENDENT SIDE EFFECTS – CHANGES OF BLOOD PRESSURE AND HEART RATE IN RELATION TO HRV
11. METHODICAL LIMITATIONS OF HRV – PARTIALLY CONTRARY RESULTS CAUSED BY THE LACK OF CONSENSUS
12. HRV ANALYSIS IN ANTIDEPRESSANT THERAPY – IMPORTANCE AND PERSPECTIVES
13. CONCLUSION – HRV FOR NON-INVASIVE IMPROVEMENT OF ANTIDEPRESSANT MONITORING
REFERENCES
INDEX